Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
22,567 | Dovepress* | 18,451+ | 1,494 | 19,945 | |
PubMed Central* | 4,116 | 894 | 5,010 | ||
Totals | 22,567 | 2,388 | 24,955 | ||
*Since 6 April 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
36 | 1 | 0 | 0 | 12 | 23 |
View citations on PubMed Central and Google Scholar